Search clinical trials for: Mild proteinuria

Total 5013 results

SkyePharma AG

Completed

Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients

Asthma

United Kingdom, Ireland
TSH Biopharm Corporation Limited

Completed

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

Hypertension | Diabetes Mellitus, Type 2 | Albuminuria

Taiwan
AstraZeneca

Completed

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease (PLANET II)

Hyperlipidemia

United States, Bulgaria, South Africa, Germany, Hungary, Romania, Canada, Denmark, Mexico, Italy, Brazil
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
Harbor Therapeutics

Completed

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Ulcerative Colitis

United States
BeneChill, Inc

Completed

Pre-ROSC Intra-Nasal Cooling Effectiveness (PRINCE)

Cardiac Arrest

Belgium, Germany, Czech Republic, Italy, Sweden
Johnson & Johnson Pharmaceutical Research & Development...
PriCara, Unit of Ortho-McNeil, Inc.

Completed

A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin

Skin Diseases, Infectious | Cellulitis
Izmir Dr Suat Seren Chest Diseases and Surgery...

Completed

The Effect of Pure Prone Positioning Therapy for the Patients With Mild to Moderate Obstructive Sleep Apnea

Obstructive Sleep Apnea

Turkey
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease
Ore Pharmaceuticals, Inc.

Unknown

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Mild to Moderate Ulcerative Colitis

Canada, India
Laval University
Pfizer; Boehringer Ingelheim

Completed

GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) (GOLD)

Physical Activity | Respiratory Symptoms | Mild Chronic Obstructive Pulmonary Disease

Canada
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
Xian-Janssen Pharmaceutical Ltd.

Completed

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Mental Disorders | Brain Diseases | Nervous System Diseases | Cognition Disorder
Nanjing University School of Medicine

Completed

Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis

Proteinuria | Focal Segmental Glomerulosclerosis

China
Janssen Cilag S.A.S.

Completed

Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)

Cardiac Arrest | Resuscitation | Cardiopulmonary
Intermountain Health Care, Inc.
Deseret Foundation

Completed

Exercise Treatment of Mild-Stage Probable Alzheimer's Disease

Dementia | Alzheimer Disease | Memory Disorders

United States
Daiichi Sankyo Co., Ltd.

Completed

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria

Japan, China
Novartis

Completed

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

Onychomycosis

France, Finland, Germany, Hungary, Iceland, Norway, Poland, Russian Federation, Spain, Turkey
Bristol-Myers Squibb

Completed

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Carcinoma, Hepatocellular

United States, Spain
Sanofi

Completed

SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction (RHOKET)

Erectile Dysfunction

France
Novartis

Completed

Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.

COPD

Denmark
Pfizer

Completed

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets (QUEST)

Alzheimer Disease

Greece
Bristol-Myers Squibb

Completed

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

HIV Infections

United States, Canada
University of Sao Paulo General Hospital

Unknown

Effects of rTMS on the Cognition of Elderly With Mild Memory Complaints (TMSMemOld)

Mild Cognitive Impairment

Brazil
Novartis Pharmaceuticals

Completed

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Onychomycosis

United States, France, Germany
Queen's University

Completed

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Takeda

Completed

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Hypertension

United States, Argentina, Peru, Mexico
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Hypertension

United States
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

Hypertension

United States, Canada, Germany, Russian Federation, France
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Albuminuria

United States, Spain, Netherlands, Canada, Italy, Mexico, Israel, Australia, Russian Federation, United Kingdom, France, Germany, Latvia, Lithuania
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

Hypertension

United States, Belgium, Canada, Germany, Russian Federation, France, Israel, Netherlands
Mansoura University

Completed

Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis

Endometriosis

Egypt
Sanofi
Bristol-Myers Squibb

Completed

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Hypertension

Egypt
Eisai Inc.
Pfizer

Completed

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Memory Loss

United States
Eisai Inc.
Pfizer

Completed

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

Alzheimer's Disease

United States
Novartis

Completed

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (KAPA)

Alzheimer's Disease

Spain
Sun Yat-sen University
ALFA WASSERMANN（BJ) Market Research and Management Co., Ltd

Unknown

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients (Soften)

Diabetic Nephropathy | Albuminuria

China
Link Medicine Corporation

Completed

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

Mild Alzheimer's Disease

United States
Novartis

Completed

Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Albuminuria
Sunnybrook Health Sciences Centre
Merck Frosst Canada Ltd.

Completed

Risk Factors Contributing to the Development of Microalbuminuria

Microalbuminuria

Canada
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

HIV Infections

United States, Puerto Rico
Lytix Biopharma AS

Completed

A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Atopic Dermatitis | Gram-positive, Skin Infections | Mild Eczema/Dermatoses

Hungary
Creabilis SA

Completed

CT 327 in the Treatment of Psoriasis Vulgaris

Psoriasis

Switzerland, United States, United Kingdom
AstraZeneca

Completed

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Alzheimer's Disease

Peru, Poland, Canada, South Africa
Takeda

Completed

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

Essential Hypertension
Adeona Pharmaceuticals

Unknown

Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease

Mild Cognitive Impairment | Alzheimer's Disease

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder

3

Subscribe